RecruitingNot ApplicableNCT06591247

Membrane Stripping for Cervical Ripening

Evaluation of Stripping for Cervical Ripening - A Randomized Controlled Study


Sponsor

Meir Medical Center

Enrollment

400 participants

Start Date

Aug 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this interventional study is to evaluate the effectiveness of membrane stripping in cervical ripening compared to double balloon catheter induction. The study population consists of women undergoing labor induction. The main questions it aims to answer are: 1. Is membrane stripping as effective as double balloon catheter induction in cervical ripening? 2. What is the influence of membrane stripping on the time required for cervical ripening, delivery duration, and maternal and fetal outcomes compared to balloon induction.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Double Baloon Catheter, a procedure called Membrane Stripping, and others for people with balloon induction, induction of birth, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDouble Baloon Catheter

A double Baloon Catheter will be inserted for 12 hours to one of the arms of the study

PROCEDUREMembrane Stripping

Stripping will be considered as 3-5 rotations of separating the amniotic sac from the cervix and will be perfomed twice (every 4-6 hours)

DRUGPGE2

A PGE2 vaginal pessary (Cervidil) will be inserted for 12-24 hours


Locations(1)

Meir Medical Center

Kfar Saba, Central District, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06591247


Related Trials